adg-126
adagene
['adg126', 'adg126 ', 'adagene']
adagene presents interim monotherapy data at esmo 2022 showing compelling safety, anti-tumor activity and pharmacokinetics of masked, anti-ctla-4 safebody adg126 in patients with advanced tumors - best-in-class profile demonstrated with repeat dosing a... 
CEO Of Digital Media Online